Compounds > debrisoquin
Page last updated: 2024-10-25

debrisoquin and Cancer of Prostate

debrisoquin has been researched along with Cancer of Prostate in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Febbo, PG1
Kantoff, PW1
Giovannucci, E1
Brown, M1
Chang, G1
Hennekens, CH1
Stampfer, M1

Other Studies

1 other study available for debrisoquin and Cancer of Prostate

ArticleYear
Debrisoquine hydroxylase (CYP2D6) and prostate cancer.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1998, Volume: 7, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Case-Control Studies; Cytochrome P-450 CYP2D6; Debrisoquin;

1998